Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analyses

Molecular and Cellular Endocrinology

Volumn 396, Issue 1-2, 2014, Pages 1-9

  Tu, Yaqin ^a,b   Yu, Qilin ^a   Fan, Guorun ^b   Yang, Ping ^a   Lai, Qiaohong ^a   Yang, Fei ^c   Zhang, Shu ^a   Wang, Wei ^a   Wang, Daowen ^a   Yu, Xuefeng ^a,b   Wang, Cong Yi ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c YANGTZE UNIVERSITY   (China)

Author keywords

ADIPOQ; Association; SNPs; Susceptibility; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HOMOZYGOTE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84907085383     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.08.006     Document Type: Article

References (50)

1. Arikoglu H., Ozdemir H., Kaya D.E., Ipekci S.H., Arslan A., Kayis S.A., et al. The Adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene 2014, 534(1):10-16.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet 2002, 3:285-298.
4. Chiodini B.D., Specchia C., Gori F., Barlera S., D'Orazio A., Pietri S., et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther. Adv. Cardiovasc. Dis 2010, 4:223-230.
5. Du W., Li Q., Lu Y., Yu X., Ye X., Gao Y., et al. Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population. Endocrine 2011, 40:413-422.
6. Filippi E., Sentinelli F., Trischitta V., Romeo S., Arca M., Leonetti F., et al. Association of the human adiponectin gene and insulin resistance. Eur. J. Hum. Genet 2004, 12:199-205.
7. Gibson F., Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004, 53:2977-2983.
8. Gonzalez-Sanchez J.L., Zabena C.A., Martinez-Larrad M.T., Fernandez-Perez C., Perez-Barba M., Laakso M., et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes. Res 2005, 13:807-812.
9. Gu H.F., Abulaiti A., Ostenson C.G., Humphreys K., Wahlestedt C., Brookes A.J., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 2004, 53(Suppl. 1):S31-S35.
10. Guo D., Li M., Zhang Y., Yang P., Eckenrode S., Hopkins D., et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat. Genet 2004, 36:837-841.
11. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
12. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
13. Heid I.M., Henneman P., Hicks A., Coassin S., Winkler T., Aulchenko Y.S., et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
14. Hivert M.F., Manning A.K., McAteer J.B., Florez J.C., Dupuis J., Fox C.S., et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008, 57:3353-3359.
15. Holst D., Grimaldi P.A. New factors in the regulation of adipose differentiation and metabolism. Curr. Opin. Lipidol 2002, 13:241-245.
16. Hu F.B., Doria A., Li T., Meigs J.B., Liu S., Memisoglu A., et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004, 53:209-213.
17. Iwata M., Maeda S., Kamura Y., Takano A., Kato H., Murakami S., et al. Genetic risk score constructed using 14 susceptibility alleles for type 2 diabetes is associated with the early onset of diabetes and may predict the future requirement of insulin injections among Japanese individuals. Diabetes Care 2012, 35:1763-1770.
18. Lee Y.Y., Lee N.S., Cho Y.M., Moon M.K., Jung H.S., Park Y.J., et al. Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabet. Med 2005, 22:569-575.
19. Li L.L., Kang X.L., Ran X.J., Wang Y., Wang C.H., Huang L., et al. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin. Exp. Pharmacol. Physiol 2007, 34:1287-1290.
20. Li X., Wei D., He H., Zhang J., Wang C., Ma M., et al. Association of the adiponectin gene (ADIPOQ) +45 T > G polymorphism with the metabolic syndrome among Han Chinese in Sichuan province of China. Asia Pac. J. Clin. Nutr 2012, 21:296-301.
21. Ling H., Waterworth D.M., Stirnadel H.A., Pollin T.I., Barter P.J., Kesaniemi Y.A., et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009, 17:737-744.
22. Matharoo K., Arora P., Bhanwer A.J. Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with type 2 diabetes in North Indian population of Punjab. Gene 2013, 527:228-234.
23. Menzaghi C., Ercolino T., Di Paola R., Berg A.H., Warram J.H., Scherer P.E., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002, 51:2306-2312.
24. Mohammadzadeh G., Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand. J. Clin. Lab. Invest 2009, 69:764-771.
25. Namvaran F., Rahimi-Moghaddam P., Azarpira N., Dabbaghmanesh M.H. Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus. Mol. Biol. Rep 2012, 39:5511-5518.
26. Nannipieri M., Posadas R., Bonotti A., Williams K., Gonzalez-Villalpando C., Stern M.P., et al. Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study. Diabetes Care 2006, 29:2509-2511.
27. Ortega-Azorin C., Sorli J.V., Asensio E.M., Coltell O., Martinez-Gonzalez M.A., Salas-Salvado J., et al. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc. Diabetol 2012, 11:137.
28. Populaire C., Mori Y., Dina C., Vasseur F., Vaxillaire M., Kadowaki T., et al. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families?. Diabetologia 2003, 46:443-445.
29. Potapov V.A., Chistiakov D.A., Dubinina A., Shamkhalova M.S., Shestakova M.V., Nosikov V.V. Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev. Diabet. Stud 2008, 5:28-37.
30. Ramya K., Ayyappa K.A., Ghosh S., Mohan V., Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 2013, 532:253-262.
31. Richards J.B., Waterworth D., O'Rahilly S., Hivert M.F., Loos R.J., Perry J.R., et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009, 5:e1000768.
32. Saxena M., Srivastava N., Banerjee M. Genetic association of adiponectin gene polymorphisms (+45T/G and +10211T/G) with type 2 diabetes in North Indians. Diabetes Metab. Syndr 2012, 6:65-69.
33. Schwarz P.E., Govindarajalu S., Towers W., Schwanebeck U., Fischer S., Vasseur F., et al. Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm. Metab. Res 2006, 38:447-451.
34. Siitonen N., Pulkkinen L., Lindstrom J., Kolehmainen M., Eriksson J.G., Venojarvi M., et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med. Genet 2011, 12:5.
35. Sikka R., Raina P., Matharoo K., Bandesh K., Bhatia R., Chakrabarti S., et al. TNF-alpha (g.-308 G > A) and ADIPOQ (g. +45 T > G) gene polymorphisms in type 2 diabetes and microvascular complications in the region of Punjab (North-West India). Curr. Eye Res 2014, Epub 14.3.21.
36. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet 2001, 68:978-989.
37. Suastika K., Dwipayana P., Saraswati M.R., Gotera W., Budhiarta A.A., Sutanegara N.D., et al. Underweight is an important risk factor for coronary heart disease in the population of Ceningan Island, Bali. Diab. Vasc. Dis. Res 2012, 9:75-77.
38. Sun H., Gong Z.C., Yin J.Y., Liu H.L., Liu Y.Z., Guo Z.W., et al. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with type 2 diabetes and rosiglitazone response in Chinese patients. Br. J. Clin. Pharmacol 2008, 65:917-926.
39. Suriyaprom K., Phonrat B., Namjuntra P., Harnroongroj T., Tungtrongchitr R. The -11377C > G adiponectin gene polymorphism alters the adiponectin concentration and the susceptibility to type 2 diabetes in Thais. Int. J. Vitam. Nutr. Res 2010, 80:216-224.
40. Szopa M., Malczewska-Malec M., Kiec-Wilk B., Skupien J., Wolkow P., Malecki M.T., et al. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol 2009, 46:317-322.
41. Takeuchi F., Ochiai Y., Serizawa M., Yanai K., Kuzuya N., Kajio H., et al. Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J. Hum. Genet 2008, 53:314-324.
42. Trayhurn P., Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc 2001, 60:329-339.
43. Tso A.W., Sham P.C., Wat N.M., Xu A., Cheung B.M., Rong R., et al. Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study. Diabetologia 2006, 49:1806-1815.
44. Ukkola O., Santaniemi M., Rankinen T., Leon A.S., Skinner J.S., Wilmore J.H., et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann. Med 2005, 37:141-150.
45. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet 2002, 11:2607-2614.
46. Vendramini M.F., Pereira A.C., Ferreira S.R., Kasamatsu T.S., Moises R.S. Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians. J. Diabetes Complications 2010, 24:115-120.
47. Vozarova de Courten B., Hanson R.L., Funahashi T., Lindsay R.S., Matsuzawa Y., Tanaka S., et al. Common polymorphisms in the Adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 2005, 54:284-289.
48. Wang C.Y., Podolsky R., She J.X. Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene. Ann. N. Y. Acad. Sci 2006, 1079:257-267.
49. Yamauchi T., Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes. (Lond) 2008, 32(Suppl. 7):S13-S18.
50. Ye E., Yang H., Chen L., Chen Q., Sun M., Lin Z., et al. Adiponectin and peroxisome proliferator-activated receptor-gamma gene polymorphisms and gene-gene interactions with type 2 diabetes. Life Sci 2014, 98:55-59.